CENTOCOR, INC.
🇺🇸United States
Clinical Trials
76
Active:0
Completed:70
Trial Phases
4 Phases
Early Phase 1:1
Phase 1:18
Phase 2:19
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (74 trials with phase data)• Click on a phase to view related trials
Phase 3
36 (48.6%)Phase 2
19 (25.7%)Phase 1
18 (24.3%)Early Phase 1
1 (1.4%)A Study to Assess the Safety and Pharmacokinetics of a Single Intravenous Administration of CNTO 328 Derived From 2 Different Cell Lines in Healthy Participants
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: CNTO 328 (Sp2/0-derived)Drug: CNTO 328 (CHO-derived)Drug: Placebo
- First Posted Date
- 2014-02-28
- Last Posted Date
- 2015-02-05
- Lead Sponsor
- Centocor, Inc.
- Target Recruit Count
- 145
- Registration Number
- NCT02074800
A Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Golimumab in Patients With Rheumatoid Arthritis (RA)
- First Posted Date
- 2011-05-30
- Last Posted Date
- 2017-10-02
- Lead Sponsor
- Centocor, Inc.
- Target Recruit Count
- 49
- Registration Number
- NCT01362153
A Study of the Pharmacokinetics of Golimumab in Chinese Male Subjects
- First Posted Date
- 2011-02-02
- Last Posted Date
- 2014-05-28
- Lead Sponsor
- Centocor, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT01288157
A Phase 3 Study of Siltuximab or Placebo in Combination With Velcade and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Phase 3
Withdrawn
- Conditions
- Multiple Myeloma
- Interventions
- Biological: Siltuximab, Velcade and dexamethasone
- First Posted Date
- 2010-12-24
- Last Posted Date
- 2013-01-28
- Lead Sponsor
- Centocor, Inc.
- Registration Number
- NCT01266811
A Study of the Pharmacokinetics of Golimumab in Japanese and Caucasian Male Subjects
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- Drug: 200 mg golimumab or placeboDrug: 400 mg golimumab or placebo
- First Posted Date
- 2010-12-13
- Last Posted Date
- 2013-09-04
- Lead Sponsor
- Centocor, Inc.
- Target Recruit Count
- 49
- Registration Number
- NCT01258777
- Prev
- 1
- 2
- 3
- 4
- 5
- 15
- Next
News
No news found